Patents by Inventor Roy Lobb

Roy Lobb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of inflammatory disorders
    Publication number: 20050226877
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Application
    Filed: April 18, 2005
    Publication date: October 13, 2005
    Applicant: BIOGEN IDEC, INC.
    Inventors: Philip Gotwals, Antonin DeFougerolles, Roy Lobb, Victor Kotelianski
  • Use of a CD40:CD154 binding interruptor to treat immunological complications of the eye
    Publication number: 20030027744
    Abstract: The invention relates generally to the treatment and inhibition of immunological complications of the eye. Such complications include unwanted immune responses resulting in an ocular inflammatory disease, resulting from a corneal or retinal graft transplantation or resulting from ocular angiogenesis, particularly ocular neovascularization. The invention relates in particular to the inhibition, treatment, or reversal of immune-system driven rejection of grafted corneal or retinal tissue or cells in a recipient host and to the treatment or inhibition of ocular inflammatory disease or ocular neovascularization in a host.
    Type: Application
    Filed: April 18, 2002
    Publication date: February 6, 2003
    Inventors: M. Reza Dana, Akshay K. Vaishnaw, Linda C. Burkly, Roy Lobb, Burt Adelman
  • Therapies for chronic renal failure using one or more integrin antagonists
    Publication number: 20030007969
    Abstract: The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain integrin antagonists.
    Type: Application
    Filed: March 12, 2002
    Publication date: January 9, 2003
    Inventors: Roy Lobb, Charles Pusey, Andrew Allen
  • Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
    Publication number: 20020197233
    Abstract: Methods of, and compositions for, treating central nervous system injury with an antagonist of an alpha4 subunit containing integrin are described.
    Type: Application
    Filed: June 13, 2002
    Publication date: December 26, 2002
    Inventors: Jane Relton, Roy Lobb, Eric Whalley, Steven P. Adams
  • Method for the treatment of inflammatory disorders
    Publication number: 20020146417
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Application
    Filed: November 30, 2001
    Publication date: October 10, 2002
    Inventors: Philip Gotwals, Antonin De Fougerolles, Roy Lobb, Victor Kotelianski